Quotes 5-day view Delayed Nasdaq
01/21/2021
01/22/2021
01/25/2021
01/26/2021
01/27/2021
Date
124.64(c)
124.61(c)
125.88(c)
120.95(c)
114.5(c)
Last
284 890
261 663
228 134
228 672
342 096
Volume
-1.46%
-0.02%
+1.02%
-3.92%
-5.33%
Change
Sales 2020
99,4 M
-
-
Net income 2020
-142 M
-
-
Net cash position 2020
759 M
-
-
P/E ratio 2020
-45,7x
Yield 2020
-
Sales 2021
164 M
-
-
Net income 2021
-125 M
-
-
Net cash position 2021
704 M
-
-
P/E ratio 2021
-55,0x
Yield 2021
-
Capitalization
6 899 M
6 899 M
-
EV / Sales 2020
61,8x
EV / Sales 2021
37,9x
Nbr of Employees
237
Free-Float
87,6%
Acceleron Pharma Inc. is a clinical-stage biopharmaceutical company. The Company is focused on the discovery, development and commercialization of therapeutics to treat serious and rare diseases. Its research focuses on key natural regulators of cellular growth and repair, particularly the Transforming Growth Factor-Beta (TGF-beta), protein superfamily. It has four internally discovered therapeutic candidates that...
Notations Surperformance© of Acceleron Pharma Inc.
Trading Rating :
Investor Rating :
All news about ACCELERON PHARMA INC.
News in other languages on ACCELERON PHARMA INC.
Analyst Recommendations on ACCELERON PHARMA INC.
Chart ACCELERON PHARMA INC.
Duration :
Auto.
2 months
3 months
6 months
9 months
1 year
2 years
5 years
10 years
Max.
Period :
Day
Week
Technical analysis trends ACCELERON PHARMA INC.
Short Term Mid-Term Long Term Trends Bearish Bullish Bullish
Income Statement Evolution
Please enable JavaScript in your browser's settings to use dynamic charts.
Mean consensus
OUTPERFORM
Number of Analysts
13
Average target price
135,38 $
Last Close Price
114,50 $
Spread / Highest target
46,7%
Spread / Average Target
18,2%
Spread / Lowest Target
-12,7%
Please enable JavaScript in your browser's settings to use dynamic charts.